Liver Care and Surveillance: The Global Impact of the COVID‐19 Pandemic
Hidenori Toyoda, Daniel Q. Huang, Michael H. Le, Mindie H. Nguyen – 17 July 2020 – As social distancing and strict stay‐at‐home orders have been instituted to slow the spread of coronavirus disease 2019 (COVID‐19), unintentional outcomes among those with chronic diseases including screening for the lethal hepatocellular carcinoma (HCC) may be occurring. We aimed to describe the changes in liver care before and after COVID‐19 restricted access to health care.